Home

Joana Goncalves

CIK 1756991 · Chief Medical Officer · last filed 2026-07-15

Joana Goncalves is a Chief Medical Officer who has filed 48 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ORKA, was dated Jul 15, 2026. Across all open-market trades the lifetime net is −$4.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.28M

Companies

2

Total Filings

48

Lifetime Open-Market Net

-$3.97M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORKA Chief Medical Officer 36,218 $90.45 $3.28M -$3.03M 10 2026-07-15
Tvardi Therapeutics, Inc. (CARA) Delisted CHIEF MEDICAL OFFICER 1,482 $15.96 $23.7K -$942.1K 35 2024-04-09

Recent Filings

48 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-15 ORKA Notice (144) −21,000 -$1.84M EDGAR
2026-07-15 ORKA Mixed — -$552.7K EDGAR
2026-06-15 ORKA Mixed −947 -$499.4K EDGAR
2026-05-15 ORKA Mixed — -$381.7K EDGAR
2026-04-15 ORKA Notice (144) −21,000 -$1.41M EDGAR
2026-04-15 ORKA Mixed — -$411.6K EDGAR
2026-03-17 ORKA Mixed −641 -$261.3K EDGAR
2026-02-17 ORKA Mixed — -$175.3K EDGAR
2026-01-23 ORKA Grant (A) +32,500 $0 EDGAR
2026-01-16 ORKA Mixed — -$171.5K EDGAR
Showing 1–10 of 48
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.